
Princeton economist Uwe Reinhardt has 
a piece on employer sponsored health insurance (ESHI) in the 
New York Times.  It ends with:
"If success in this regard serves to shrink the traditional employment-based insurance system, so be it.”
 It’s not the outcome, it’s the plan.  The race continues to the lowest global common denominator on worker pay/benefits.  Employers want to dump the employment-based insurance system.  Uwe provides a nice cover in his piece.
 As for Uwe, I hope he declared his conflicts of interests. He sits on a number of for-profit health care boards and owns huge chunks of stock, including options. 
 He just got options for 6,230 shares of AmeriGroup stock, a health insurer. They become exercisable in 2010 and last through 2016. Uwe also holds 144,558 AmeriGroup shares, 134,856 of which are options.  Dr. Reinhardt has a strong incentive to see AmeriGroup's stock price grow.  It would help if Obama’s "public plan" is really a public-private hybrid. AmeriGroup excels at that.  Dr. Reinhardt's Board pay from AmeriGroup in 2008 was $226,531.
 Uwe made $2.3 million off the sale of 
Triad Hospitals and has a big chunk of stock in 
Boston Scientific (63,625 shares of BSX). Reinhardt's 2008 Boston Scientific 
Board compensation was $241,740.  White House Health Czar Nancy Ann DeParle sat on the Triad and BSX boards with Uwe.   However, the health economist sits on other boards, even a 
private equity underwriter (PEU):
Dr. Reinhardt is a Trustee of the H&Q Healthcare Investors, H&Q Life Sciences Investors and Hambrecht & Quist Capital Management LLC. He is a member of the boards of directors of Amerigroup Corporation and Legacy Hospital Partners, Inc.
Nancy Ann DeParle was 
a PEU and sat on the Legacy Hospital Partner board, founded by ex-Triad CEO Denny Shelton.  Funny, the Obama/Summers/Orzag/
Emanuel lingo on health reform sounds alot like 
Denny circa 2007. A little bit louder now!  Hey, hey, hey hey!  Uwe, Uwe!  ESHI gotta go!